Mitochondrial dysfunction in ocular disease: Focus on glaucoma

Mitochondrion
Khalid KamelColm O'Brien

Abstract

Mitochondrial dysfunction commonly presents with ocular findings as a part of a systemic disorder. These ophthalmic manifestations can be the first sign of a mitochondrial abnormality, which highlights the key role of a comprehensive ophthalmic assessment. On the other hand, a number of visually disabling genetic and acquired eye diseases with no curative treatment show abnormal mitochondrial function. Recent advances in mitochondrial research have improved our understanding of previously unexplained ocular disorders utilising better diagnostic approaches. Further studies on mitochondrial dysfunction and novel modalities of treatment will help to improve outcomes of these conditions. In this review article we discuss the clinical picture of common mitochondrial-related eye diseases, diagnostic approaches and possible treatment options including a very recent interesting report about gene therapy, with a particular focus on glaucoma.

Citations

Dec 8, 2017·Frontiers in Neuroscience·Leanne T Y CheungKin Chiu
Jan 2, 2018·BioResearch Open Access·Walter H MoosKrishna Kodukula
Sep 8, 2018·Investigative Ophthalmology & Visual Science·Stéphanie LeruezJuan Manuel Chao de la Barca
Feb 23, 2019·Autophagy·Thomas G McWilliamsIan G Ganley
Jan 25, 2020·Journal of Glaucoma·Hanhan LiuVerena Prokosch
Apr 21, 2018·International Journal of Molecular Sciences·Timothy E YapMaria Francesca Cordeiro
Aug 12, 2018·Investigative Ophthalmology & Visual Science·Ying ZhuTatjana C Jakobs
Mar 14, 2020·International Journal of Molecular Sciences·Ines RosignolPatricia Boya
May 16, 2019·Tissue Engineering. Part B, Reviews·Pascal A M M VroemenJan de Boer
May 1, 2020·BioMed Research International·Holly R Chinnery, Kate E Keller
Jul 10, 2019·Investigative Ophthalmology & Visual Science·Yaoming LiuXiulan Zhang
Oct 22, 2020·Nutrients·Annagrazia AdornettoRossella Russo
Nov 3, 2020·Investigative Ophthalmology & Visual Science·Khalid KamelMustapha Irnaten
Feb 15, 2021·Survey of Ophthalmology·Luciano QuarantaIvano Riva
Nov 5, 2020·The EPMA Journal·Adriana Torres CrignaOlga Golubnitschaja
Feb 16, 2018·American Journal of Ophthalmology·Huiyuan HouRobert N Weinreb
Jun 23, 2021·Investigative Ophthalmology & Visual Science·Wouter H G HubensTheo G M F Gorgels
Jul 3, 2021·Nutrients·Drake W LemPinakin Gunvant Davey
Jul 3, 2021·Molecular & Cellular Proteomics : MCP·Xiaoyan LiuWei Sun
Aug 10, 2021·Frontiers in Pharmacology·Assraa Hassan JassimClaire H Mitchell
Apr 24, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Liujiu TangHaiying Ma
Aug 12, 2019·Ophthalmic Research·Timothy E YapM Francesca Cordeiro

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Clinics in Chest Medicine
W Tsiaras, M Gridley
Molecular and Cellular Neurosciences
Alicia M PickrellCarlos T Moraes
Annals of Ophthalmology
M H Friedlaender, G Smolin
Dialogues in Clinical Neuroscience
Jessica R Grisham, Melissa M Norberg
© 2022 Meta ULC. All rights reserved